Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 1, 2026 22:54 UTC |
Kaye Edward M. MDDirector
|
SaleCommon Stock | 2,933 | $76.09 | $223,171.97 |
DisclosureSEC source: 0001061983-26-000066 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,283 Read SEC document |
| June 01, 2026 Filed Jun 1, 2026 22:51 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.26 | $0.00 |
DisclosureSEC source: 0001061983-26-000065 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 15,000 shares Expires 2031-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| June 01, 2026 Filed Jun 1, 2026 22:51 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 15,000 | $74.08 | $1,111,200.00 |
DisclosureSEC source: 0001061983-26-000065 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,555 Read SEC document |
| June 01, 2026 Filed Jun 1, 2026 22:51 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 15,000 | $23.26 | $348,900.00 |
DisclosureSEC source: 0001061983-26-000065 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:10 UTC |
PARSHALL B LYNNEDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000057 · form4.xml · derivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:10 UTC |
PARSHALL B LYNNEDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000057 · form4.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,784 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:16 UTC |
Bhanji MunaDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000062 · form4.xml · derivative · entry 2 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:16 UTC |
Bhanji MunaDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000062 · form4.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,361 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:14 UTC |
Daly James MDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000061 · form4.xml · derivative · entry 2 Daly James M · CIK 0001560782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:14 UTC |
Daly James MDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000061 · form4.xml · nonDerivative · entry 1 Daly James M · CIK 0001560782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,239 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:13 UTC |
Harrington Robert ArthurDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000060 · form4.xml · derivative · entry 2 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:13 UTC |
Harrington Robert ArthurDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000060 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,781 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:12 UTC |
HENDERSON JOHN TDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000059 · form4.xml · derivative · entry 3 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:12 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000059 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,088 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:11 UTC |
Kaye Edward M. MDDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000058 · form4.xml · derivative · entry 2 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:11 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000058 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,216 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:09 UTC |
Landry Robert EDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000056 · form4.xml · derivative · entry 2 Landry Robert E · CIK 0001585160 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:09 UTC |
Landry Robert EDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000056 · form4.xml · nonDerivative · entry 1 Landry Robert E · CIK 0001585160 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,184 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:08 UTC |
WIERENGA WENDELLDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000055 · form4.xml · derivative · entry 2 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:08 UTC |
WIERENGA WENDELLDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000055 · form4.xml · nonDerivative · entry 1 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,488 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:07 UTC |
Wysenski NancyDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,301 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001061983-26-000054 · form4.xml · derivative · entry 2 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,301 Underlying: Common Stock · 4,301 shares Expires 2036-05-26 Read SEC document |
| May 27, 2026 Filed May 27, 2026 23:07 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000054 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,917 Read SEC document |
| May 27, 2026 Filed May 28, 2026 20:21 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $77.21 | $579,075.00 |
DisclosureSEC source: 0001061983-26-000063 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 392,830 Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:00 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-26-000053 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,886 Underlying: Common Stock · 3,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:00 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,500 | $75.69 | $264,915.00 |
DisclosureSEC source: 0001061983-26-000053 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,902 Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:00 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 3,500 | $7.80 | $27,300.00 |
DisclosureSEC source: 0001061983-26-000053 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2026 Filed May 14, 2026 20:26 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $77.92 | $584,400.00 |
DisclosureSEC source: 0001061983-26-000052 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,330 Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:18 UTC |
Lee SungEVP, Chief Financial Officer
|
SaleCommon Stock | 23,906 | $76.87 | $1,837,654.22 |
DisclosureSEC source: 0001061983-26-000049 · form4.xml · nonDerivative · entry 1 Lee Sung · CIK 0001793200 · EVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,221 Read SEC document |
| May 05, 2026 Filed May 5, 2026 21:35 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-26-000051 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,386 Underlying: Common Stock · 3,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 5, 2026 21:35 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,500 | $77.37 | $270,795.00 |
DisclosureSEC source: 0001061983-26-000051 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,902 Read SEC document |
| May 05, 2026 Filed May 5, 2026 21:35 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 3,500 | $7.80 | $27,300.00 |
DisclosureSEC source: 0001061983-26-000051 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:20 UTC |
WIERENGA WENDELLDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 4,032 | $0.00 Strike: $12.40 | $0.00 |
DisclosureSEC source: 0001061983-26-000050 · form4.xml · derivative · entry 3 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,032 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest and become exercisable as to 4,032 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2018. Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:20 UTC |
WIERENGA WENDELLDirector
|
SaleCommon Stock | 4,032 | $75.00 | $302,400.00 |
DisclosureSEC source: 0001061983-26-000050 · form4.xml · nonDerivative · entry 2 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,637 Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:20 UTC |
WIERENGA WENDELLDirector
|
Exercise / conversionCommon Stock | 4,032 | $12.40 | $49,996.80 |
DisclosureSEC source: 0001061983-26-000050 · form4.xml · nonDerivative · entry 1 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:11 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 11,333 | $0.00 Strike: $39.13 | $0.00 |
DisclosureSEC source: 0001061983-26-000047 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,070 Underlying: Common Stock · 11,333 shares Expires 2033-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:11 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 11,333 | $77.25 | $875,474.25 |
DisclosureSEC source: 0001061983-26-000047 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,555 Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:11 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 11,333 | $39.13 | $443,460.29 |
DisclosureSEC source: 0001061983-26-000047 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:15 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001061983-26-000048 · form4.xml · derivative · entry 4 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:15 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 20,000 | $75.97 | $1,519,400.00 |
DisclosureSEC source: 0001061983-26-000048 · form4.xml · nonDerivative · entry 2 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,237 Read SEC document |
| May 05, 2026 Filed May 5, 2026 20:15 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 20,000 | $7.61 | $152,200.00 |
DisclosureSEC source: 0001061983-26-000048 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:01 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 15,857 | $0.00 Strike: $37.63 | $0.00 |
DisclosureSEC source: 0001061983-26-000046 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,857 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:01 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 15,857 | $65.00 | $1,030,705.00 |
DisclosureSEC source: 0001061983-26-000046 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,555 Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:01 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 15,857 | $37.63 | $596,698.91 |
DisclosureSEC source: 0001061983-26-000046 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2026 Filed Apr 30, 2026 20:22 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.26 | $0.00 |
DisclosureSEC source: 0001061983-26-000045 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 15,000 shares Expires 2031-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| April 30, 2026 Filed Apr 30, 2026 20:22 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 15,000 | $63.26 | $948,900.00 |
DisclosureSEC source: 0001061983-26-000045 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,555 Read SEC document |
| April 30, 2026 Filed Apr 30, 2026 20:22 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 15,000 | $23.26 | $348,900.00 |
DisclosureSEC source: 0001061983-26-000045 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2026 Filed Apr 29, 2026 20:23 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $59.62 | $447,150.00 |
DisclosureSEC source: 0001061983-26-000044 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 407,830 Read SEC document |
| April 21, 2026 Filed Apr 21, 2026 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-26-000043 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,886 Underlying: Common Stock · 3,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2026 Filed Apr 21, 2026 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,500 | $65.69 | $229,915.00 |
DisclosureSEC source: 0001061983-26-000043 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,902 Read SEC document |
| April 21, 2026 Filed Apr 21, 2026 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 3,500 | $7.80 | $27,300.00 |
DisclosureSEC source: 0001061983-26-000043 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.